Senior Vice President of Center for Neuroscience and Behavioral Medicine; Director, Gilbert Neurofibromatosis Institute; Director, Brain Tumor Institute
Children's National Hospital
Dr. Packer has been heavily involved in clinical and applied basic science research. His clinical research has touched on various aspects of adult and child neurology and neuro-oncology, including adult and pediatric brain tumors, neurofibromatosis type 1, the neurologic aspects of childhood neurogenetic diseases, and multiple other topics in general child neurology. Much of his research has focused on the development and performance of clinical trials for adults and children with neurologic, neuro-oncologic and neurogenetic disorders, and he has received peer-reviewed grant support for this research. Many of the clinical trials in neurofibromatosis and brain tumors are translational, bringing advances from the bench to the bedside expeditiously.
Children’s National Hospital
Medulloblastomas comprises the vast majority of pediatric embryonal tumors and by definition arise in the posterior fossa, where they constitute approximately 40% of all posterior fossa tumors. Other forms of embryonal tumors each make up 2% or less of all childhood brain tumors.The clinical feature
Low-Grade Gliomas also called astrocytomas are the most common cancer of the central nervous system in children. They represent a heterogeneous group of tumors that can be discovered anywhere within the brain or spinal cord. Although surgical resection may be curative, up to 20% of children still su